Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Intellia Thera CS (NQ: NTLA ) 15.14 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Intellia Thera CS < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > Macy's, Palo Alto Networks And Other Big Gainers From Tuesday August 24, 2022 U.S. stocks closed mostly lower with the Dow Jones dropping more than 150 points on Tuesday. Here is the list of some big stocks moving higher in the previous session. Via Benzinga 7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher August 17, 2022 These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up. Via InvestorPlace 7 Stock Price Predictions That Are Actually Worth Listening To August 12, 2022 Investors may take advantage of analyst stock price predictions beyond the recent share price to discover promising investments. Via InvestorPlace Pfizer Is Reportedly In 'Advanced Talks' To Buy Global Blood Therapeutics For $5 Billion August 05, 2022 Shares of Pfizer's rumored takeover target have rocketed for two days running. Via Investor's Business Daily Expert Ratings for Intellia Therapeutics August 05, 2022 Within the last quarter, Intellia Therapeutics (NASDAQ:NTLA) has observed the following analyst ratings: Via Benzinga Recap: Intellia Therapeutics Q2 Earnings August 04, 2022 Intellia Therapeutics (NASDAQ:NTLA) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Via Benzinga Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis June 24, 2022 Via Benzinga Alnylam's Hot Streak Cools As Expert Questions Uptake For Its Heart Drug August 05, 2022 The company will compete with Pfizer, which already has an approved drug. Via Investor's Business Daily Clorox, Crocs And Some Other Big Stocks Moving Lower On Thursday August 04, 2022 AMTD Digital Inc. (NYSE: HKD) dipped 43.6% to $620.00 on possible profit taking after the stock surged over the last few trading days. Via Benzinga Intellia Gives Back Alnylam-Inspired Gains As Gene-Editing Safety Questioned August 04, 2022 Intellia is backing off the higher dose of a gene-editing drug in cardiomyopathy patients. Via Investor's Business Daily Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate August 04, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga BMO Initiates Coverage On This Gene Editing Spearhead June 17, 2022 Via Benzinga Why Are Gene Editing Stocks NTLA, ALNY, CRSP, BEAM Up Today? August 03, 2022 Gene editing stocks are a bright spot on the market today after Alnylam announced the success of one of its RNAi therapies, Patisiran. Via InvestorPlace 7 Cathie Wood Stocks Trading at a Discount Right Now July 26, 2022 These 7 Cathie Wood stocks are the best choices to buy in June. COIN, FATE, NTLA, MELI, TDOC, TSLA, and ZM can make excellent investments. Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session July 20, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga The 3 Leaders of the Gene Editing Revolution July 08, 2022 There's a wide field of gene editing stocks, but if you're looking for the best opportunities, there are a few likely winners to watch. Via InvestorPlace 4 Analysts Have This to Say About Intellia Therapeutics April 28, 2022 Analysts have provided the following ratings for Intellia Therapeutics (NASDAQ:NTLA) within the last quarter: Via Benzinga 7 Moonshot Investments Upending a $10 Trillion Industry July 08, 2022 Gene editing is expensive at an estimated $5 billion per drug, but it could change the world in the very near future. Via InvestorPlace Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names July 06, 2022 Biotech stocks continued going gangbusters Wednesday. Here's why, experts say. Via Investor's Business Daily Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying July 06, 2022 Biotech stocks continued going gangbusters Wednesday. Here's why, experts say. Via Investor's Business Daily Analyst Ratings for Intellia Therapeutics June 16, 2022 Over the past 3 months, 7 analysts have published their opinion on Intellia Therapeutics (NASDAQ:NTLA) stock. These analysts are typically employed by large Wall Street banks and tasked with... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022 June 16, 2022 Upgrades Via Benzinga Analyst Ratings for Intellia Therapeutics May 24, 2022 Over the past 3 months, 8 analysts have published their opinion on Intellia Therapeutics (NASDAQ:NTLA) stock. These analysts are typically employed by large Wall Street banks and tasked with... Via Benzinga 10 Biggest Price Target Changes For Monday May 09, 2022 Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading. Via Benzinga The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study May 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Preview For Intellia Therapeutics May 04, 2022 Intellia Therapeutics (NASDAQ:NTLA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga How To Attend Intellia Therapeutics Q1 2022 Earnings Conference Call May 02, 2022 Intellia Therapeutics (NASDAQ:NTLA) will host a conference call at 08:00 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022 April 28, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Thursday April 21, 2022 On Thursday, 236 companies hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday April 20, 2022 On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... Via Benzinga < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
